Jun'04 | Jun'05 | Jun'06 | Jul'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research & Development Expenses (R&D) | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $2,344.0K | $2,472.0K | $1,622.0K | $748.0K | $916.0K | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Jun'04 | Jun'05 | Jun'06 | Jul'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 270.7 0.0% | 275.2 1.7% | 322.5 17.2% | 368.0 14.1% | 392.9 6.8% | 276.0 (29.8%) | 202.0 (26.8%) | 247.9 22.7% | 334.3 34.9% | 323.3 (3.3%) | 313.4 (3.1%) | 327.6 4.5% | 318.3 (2.9%) | 347.4 9.2% | 376.1 8.2% | 362.7 (3.5%) | 395.5 9.0% | 626.7 58.5% | 782.4 24.8% | 836.5 6.9% |
Cost of Goods Sold (COGS) | 245.8 | 249.9 | 277.3 | 321.9 | 388.7 | 310.1 | 171.4 | 225.0 | 309.3 | 302.0 | 285.0 | 269.1 | 253.0 | 271.4 | 292.5 | 286.2 | 296.7 | 427.8 | 529.1 | 531.8 |
% margin | 24.9 9.2% | 25.2 9.2% | 45.2 14.0% | 46.1 12.5% | 4.2 1.1% | (34.1) (12.4%) | 30.5 15.1% | 22.9 9.2% | 25.0 7.5% | 21.2 6.6% | 28.4 9.1% | 58.5 17.9% | 65.3 20.5% | 76.0 21.9% | 83.6 22.2% | 76.5 21.1% | 98.8 25.0% | 199.0 31.7% | 253.3 32.4% | 304.7 36.4% |
Operating Expenses | 9.6 | 18.6 | 22.8 | 18.9 | 33.9 | 26.1 | 23.3 | 22.0 | 26.0 | 26.4 | 20.1 | 25.7 | 23.3 | 33.1 | 33.5 | 29.3 | 44.6 | 88.9 | 104.3 | 156.1 |
Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 | 2.5 | 1.6 | 0.7 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative Expenses (SG&A) | 20.3 | 19.3 | 23.8 | 20.3 | 24.2 | 21.4 | 20.7 | 21.2 | 26.5 | 26.2 | 20.1 | 25.7 | 26.7 | 33.1 | 33.5 | 29.3 | 44.6 | 88.9 | 104.3 | 129.6 |
% margin | 15.3 5.6% | 6.6 2.4% | 22.4 6.9% | 27.2 7.4% | (29.7) (7.5%) | (79.0) (28.6%) | 7.3 3.6% | 0.6 0.3% | (0.9) (0.3%) | (5.2) (1.6%) | 16.6 5.3% | 32.9 10.0% | 42.0 13.2% | 42.9 12.3% | 50.1 13.3% | 47.2 13.0% | 54.2 13.7% | 93.7 15.0% | 149.0 19.0% | 148.6 17.8% |
Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 2.3 | 4.0 | 5.5 | 0.0 |
Interest Expense | 1.1 | 1.4 | 1.5 | 1.0 | 1.5 | 2.9 | 1.8 | 0.4 | 0.9 | 1.1 | 0.8 | 0.5 | 1.3 | 1.2 | 1.2 | 1.3 | 1.6 | 4.0 | 5.5 | 6.6 |
Pre-tax Income | 15.7 | 6.1 | 21.0 | 27.7 | (23.6) | (81.9) | 4.0 | (1.2) | 1.9 | (6.5) | 25.9 | 38.4 | 44.7 | 52.8 | 49.0 | 45.9 | 52.6 | 121.1 | 140.2 | 141.7 |
% effective tax rate | 6.2 39.5% | 2.1 34.6% | 7.0 33.4% | 10.0 36.1% | (11.9) 50.2% | (12.8) 15.6% | (4.8) (120.1%) | 0.1 (5.5%) | 0.3 16.4% | (0.7) 10.9% | 2.3 8.7% | 12.2 31.8% | 13.5 30.3% | 10.9 20.7% | 11.7 23.9% | 7.1 15.6% | 12.3 23.3% | 30.3 25.0% | 31.3 22.3% | 34.6 24.4% |
% margin | 9.5 3.5% | 4.0 1.5% | 14.0 4.3% | 17.7 4.8% | (11.7) (3.0%) | (69.1) (25.0%) | 8.7 4.3% | (1.3) (0.5%) | 1.6 0.5% | (4.9) (1.5%) | 23.7 7.6% | 26.2 8.0% | 31.2 9.8% | 41.8 12.0% | 37.3 9.9% | 38.8 10.7% | 40.3 10.2% | 91.3 14.6% | 109.5 14.0% | 107.5 12.8% |
EPS | 0.61 | 0.25 | 0.87 | 1.08 | (0.71) | (4.17) | 0.52 | (0.08) | 0.09 | (0.29) | 1.32 | 1.48 | 1.82 | 2.44 | 2.21 | 2.27 | 2.37 | 4.37 | 4.94 | 4.82 |
Diluted EPS | 0.59 | 0.24 | 0.83 | 1.05 | (0.70) | (4.17) | 0.51 | (0.08) | 0.09 | (0.29) | 1.32 | 1.48 | 1.82 | 2.44 | 2.21 | 2.27 | 2.37 | 4.32 | 4.92 | 4.80 |
% margin | 22.6 8.4% | 35.0 12.7% | 41.6 12.9% | (10.2) (2.8%) | (67.1) (17.1%) | 14.4 5.2% | 13.7 6.8% | 13.1 5.3% | 14.4 4.3% | 6.6 2.0% | 19.8 6.3% | 45.2 13.8% | 49.8 15.7% | 54.2 15.6% | 61.5 16.4% | 58.8 16.2% | 67.2 17.0% | 117.0 18.7% | 167.1 21.4% | 170.5 20.4% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of today, MGP Ingredients, Inc.'s last 12-month Research & Development Expenses (R&D) is $0.0, based on the financial report for Dec 31, 2024 (Q4’2024).
Over the last year, MGP Ingredients, Inc.'s Research & Development Expenses (R&D) growth was N/A. The average annual Research & Development Expenses (R&D) growth rates for MGP Ingredients, Inc. have been N/A over the past three years, N/A over the past five years.